back
09 Mar 2022

DPI CDC annonce accord avec KELIX bio pour acquérir PHI lors d’un 2ème

https://www.dpi-llp.com/wp-content/uploads/2022/03/DPI-CDC-annonce-accord-avec-KELIX-bio-pour-acquerir-PHI-lors-dun-2eme-Final.pdf

Related articles

Kazyon attracts $165 million investment from DPI-led consortium
| 27 Apr 2023
DPI-led consortium to buy Solevo, a leading African distributor of specialty chemicals from Helios
| 19 Apr 2023
Marcyrl attracts new investment from DPI and Amethis
| 06 Apr 2023
See all news
Copyright © DPI 2023